4.7 Review

The role of ATP-binding cassette transporters in neuro-inflammation: relevance for bioactive lipids

Journal

FRONTIERS IN PHARMACOLOGY
Volume 3, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2012.00074

Keywords

ATP-binding cassette transporters; blood brain barrier; multiple sclerosis; astrocytes; bioactive lipids; platelet-activating factor; chemokines

Funding

  1. NIAAA NIH HHS [R01 AA017408] Funding Source: Medline
  2. NIA NIH HHS [R01 AG023471] Funding Source: Medline
  3. NIDA NIH HHS [R01 DA024593] Funding Source: Medline
  4. NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE ON AGING [R01AG023471] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017408] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024593] Funding Source: NIH RePORTER

Ask authors/readers for more resources

ATP-binding cassette (ABC) transporters are highly expressed by brain endothelial cells that form the blood brain barrier (BBB). These efflux pumps play an important role in maintaining brain homeostasis as they actively hinder the entry of unwanted blood-derived compounds into the central nervous system (CNS). Consequently, their high activity at the BBB has been a major hurdle for the treatment of several brain diseases, as they prevent numerous drugs to reach their site of action within the brain. Importantly, recent data indicate that endogenous substrates for ABC transporters may include inflammatory mediators, such as prostaglandins, leukotrienes, cytokines, chemokines, and bioactive lipids, suggesting a potential role for ABC transporters in immunological responses, and more specifically in inflammatory brain disorders, such as multiple sclerosis (MS). In this review, we will give a comprehensive overview of recent findings that illustrate this novel role for ABC transporters in neuro-inflammatory processes. Moreover, we will provide first insights into underlying mechanisms and focus on the importance for bioactive lipids, in particular platelet-activating factor, herein. A thorough understanding of these events may form the basis for the development for selective treatment modalities to dampen the neuro-inflammatory attack in MS and thereby reducing tissue damage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available